Compare · MTEX vs RGC
MTEX vs RGC
Side-by-side comparison of Mannatech Incorporated (MTEX) and Regencell Bioscience Holdings Limited (RGC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MTEX and RGC operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- RGC is the larger of the two at $8.27B, about 789.5x MTEX ($10.5M).
- Over the past year, MTEX is down 51.8% and RGC is down 77.2% - MTEX leads by 25.4 points.
- MTEX has been more active in the news (6 items in the past 4 weeks vs 2 for RGC).
PerformanceMTEX-51.83%RGC-77.22%
2025-06-17+0.00%2026-06-16
- Company
- Mannatech Incorporated
- Regencell Bioscience Holdings Limited
- Price
- $5.40+0.84%
- $17.77+3.80%
- Market cap
- $10.5M
- $8.27B
- 1M return
- +21.21%
- -38.66%
- 1Y return
- -51.83%
- -77.22%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- News (4w)
- 6
- 2
- Recent ratings
- 0
- 0
MTEX
Mannatech Incorporated
Mannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management products. The company primarily sells its products directly, as well as through network marketing channels and a website. Mannatech, Incorporated was founded in 1993 and is headquartered in Flower Mound, Texas.
Latest MTEX
- Mannatech Incorporated filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Mannatech Announces Appointment of Yasir Haider as Chief Financial Officer
- SEC Form 4 filed by Director Toth Robert
- SEC Form 4 filed by Director John Seifrick A
- Mannatech Incorporated filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Mannatech Announces Results of Annual Shareholders' Meeting
- Director Jobe Larry A bought $11,548 worth of shares (2,803 units at $4.12), increasing direct ownership by 4% to 70,000 units (SEC Form 4)
- Director Jobe Larry A bought $21,000 worth of shares (5,000 units at $4.20), increasing direct ownership by 8% to 67,197 units (SEC Form 4)
- Director Robbins Kevin Andrew bought $29,607 worth of shares (7,100 units at $4.17), increasing direct ownership by 27% to 33,333 units (SEC Form 4)
- Mannatech Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
Latest RGC
- SEC Form 4 filed by Director Lo William Wing Yan Dr
- SEC Form 4 filed by Director Hui Evana Yee Wah
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 424B5 filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited